Evaluation of inflammatory serum parameters as a diagnostic tool in patients with endometriosis : a case-control study
This case-control study evaluated inflammatory serum parameters as a diagnostic tool for identifying patients with endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This case-control study evaluated the diagnostic potential of inflammatory serum markers hepcidin, suPar, and IL-6 in distinguishing patients with endometriosis from controls. The researchers analyzed data from 87 participants, utilizing a supervised machine learning tree classifier trained on these biomarkers to predict disease status. The model achieved an overall accuracy of 80% during external validation, demonstrating that IL-6 and suPar levels significantly differ between those with and without the condition. This paper is centrally about endometriosis — specifically investigating non-invasive serum biomarkers for its diagnosis.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Full text
1,937 characters
· extracted from
oa-html
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00